Urteste SA Net Assets
Urteste SA net assets. Based on the latest financial reports, Urteste SA (URT) has net assets worth zł23.79 Million PLN (≈ $6.55 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł40.53 Million ≈ $11.16 Million USD) and total liabilities (zł16.75 Million ≈ $4.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore URT net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł23.79 Million |
| % of Total Assets | 58.69% |
| Annual Growth Rate | 75.19% |
| 5-Year Change | 256.91% |
| 10-Year Change | N/A |
| Growth Volatility | 245.64 |
Net Assets of Urteste SA (2019–2025)
Net assets of Urteste SA from 2019 to 2025. This chart illustrates how Urteste SA's net assets have evolved over time, based on quarterly financial data. See Urteste SA balance sheet independence to measure how much of total assets are equity-financed.
Annual Net Assets for Urteste SA (2019–2025)
The table below shows the annual net assets of Urteste SA from 2019 to 2025. For live market cap and overall valuation, see Urteste SA (URT) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł34.58 Million ≈ $9.52 Million |
+43.41% |
| 2024-12-31 | zł24.11 Million ≈ $6.64 Million |
-13.09% |
| 2023-12-31 | zł27.74 Million ≈ $7.64 Million |
+393.56% |
| 2022-12-31 | zł5.62 Million ≈ $1.55 Million |
-41.98% |
| 2021-12-31 | zł9.69 Million ≈ $2.67 Million |
+609.71% |
| 2020-12-31 | zł1.37 Million ≈ $375.68K |
+14.20% |
| 2019-12-31 | zł1.20 Million ≈ $328.95K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Urteste SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 561626400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Urteste SA Net Assets Breakdown (December 2025)
Urteste SA net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | zł153.00K | 0.61% |
| Other Comprehensive Income | zł-1.75 Million | -7.02% |
| Other Components | zł32.51 Million | 130.40% |
| Total Equity | zł24.93 Million | 100.00% |
Urteste SA Competitors by Market Cap
The table below lists competitors of Urteste SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rajshree Polypack Limited
NSE:RPPL
|
$17.22 Million |
|
Primega Group Holdings Limited Ordinary Shares
NASDAQ:PGHL
|
$17.22 Million |
|
Kota Satu Properti Tbk PT
JK:SATU
|
$17.24 Million |
|
Wicaksana Overseas International
JK:WICO
|
$17.25 Million |
|
Zodiac Energy Limited
NSE:ZODIAC
|
$17.22 Million |
|
Anoto Group AB
ST:ANOT
|
$17.20 Million |
|
Samyang Holdings Corp
KO:000075
|
$17.20 Million |
|
Superhouse Limited
NSE:SUPERHOUSE
|
$17.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Urteste SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 24,111,000 to 24,928,000, a change of 817,000 (3.4%).
- Net loss of 5,981,000 reduced equity.
- New share issuances of 4,440,000 increased equity.
- Other comprehensive income decreased equity by 3,623,000.
- Other factors increased equity by 5,981,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-5.98 Million | -23.99% |
| Share Issuances | zł4.44 Million | +17.81% |
| Other Comprehensive Income | zł-3.62 Million | -14.53% |
| Other Changes | zł5.98 Million | +23.99% |
| Total Change | zł- | 3.39% |
Book Value vs Market Value Analysis
This analysis compares Urteste SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.32x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 20.42x to 2.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | zł2.01 | zł41.00 | x |
| 2020-12-31 | zł1.13 | zł41.00 | x |
| 2021-12-31 | zł9.21 | zł41.00 | x |
| 2022-12-31 | zł4.95 | zł41.00 | x |
| 2023-12-31 | zł21.46 | zł41.00 | x |
| 2024-12-31 | zł17.10 | zł41.00 | x |
| 2025-12-31 | zł17.67 | zł41.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Urteste SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -23.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -27186.36%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.81x
- Recent ROE (-23.99%) is above the historical average (-37.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -30.52% | 0.00% | 0.00x | 1.04x | zł-484.26K |
| 2020 | -78.63% | 0.00% | 0.00x | 2.05x | zł-597.66K |
| 2021 | -23.97% | 0.00% | 0.00x | 1.03x | zł-3.29 Million |
| 2022 | -72.23% | -135333.33% | 0.00x | 1.19x | zł-4.62 Million |
| 2023 | -20.13% | -420.00% | 0.04x | 1.07x | zł-8.36 Million |
| 2024 | -15.06% | -201.72% | 0.06x | 1.23x | zł-6.04 Million |
| 2025 | -23.99% | -27186.36% | 0.00x | 1.81x | zł-8.47 Million |
Industry Comparison
This section compares Urteste SA's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $181,099,663
- Average return on equity (ROE) among peers: -4.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Urteste SA (URT) | zł23.79 Million | -30.52% | 0.70x | $17.22 Million |
| Bioton S.A. (BIO) | $1.34 Billion | 2.83% | 0.43x | $80.35 Million |
| Captor Therapeutics S.A. (CTX) | $96.32 Million | -37.26% | 0.17x | $80.35 Million |
| Mabion S.A. (MAB) | $111.44 Million | -5.68% | 0.43x | $35.14 Million |
| Molecure S.A. (MOC) | $81.89 Million | -4.61% | 0.05x | $32.77 Million |
| Nanogroup SA (NNG) | $7.78 Million | -10.77% | 1.47x | $20.80 Million |
| Pharmena S.A. (PHR) | $13.08 Million | -31.23% | 0.29x | $9.07 Million |
| PolTREG S.A. (PTG) | $101.04 Million | -1.95% | 0.22x | $27.34 Million |
| Pure Biologics Spólka Akcyjna (PUR) | $39.49 Million | -33.10% | 0.20x | $4.61 Million |
| Ryvu Therapeutics SA (RVU) | $9.25 Million | 63.22% | 1.90x | $108.04 Million |
| Synthaverse S.A. (SVE) | $14.06 Million | 18.07% | 4.23x | $55.05 Million |
About Urteste SA
Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.